文献速递骨肌MRCT

四肢滑膜肉瘤的预后因素:影像学至关重要

Prognostic factors of the synovial sarcoma of the extremities: imaging does matter.
PubMed 文献 · Eur Radiol · 2022-08-18

这项回顾性多中心研究纳入98例四肢滑膜肉瘤患者,评估影像学指标与总生存期(OS)的关系。多因素Cox回归显示,组织学分级(HR=2.71)、MRI肿瘤大小(HR=1.02)和CT钙化(HR=0.10)是OS的独立预后因素,提示影像生物标志物可预测长期结局,CT钙化与良好预后相关。

要点

  • MRI肿瘤大小是四肢滑膜肉瘤的独立预后因素,每增加1mm风险比1.02。
  • CT上存在钙化与更好的总生存期独立相关(HR=0.10)。
  • 组织学分级仍是独立预后因素,高级别预后更差。

关键影像表现/征象

  • MRI上滑膜肉瘤平均长轴直径为67.5 ± 38.3 mm。
  • CT扫描上44%(15/34)的病灶可见钙化。
  • 滑膜肉瘤病灶多数为2级(57/98;58%)。

诊断标准与关键数值

  • 多因素Cox回归显示组织学分级是OS的独立预后因素(HR=2.71;95%CI=1.30-5.66;p=0.008)。
  • MRI测量的病灶大小是OS的独立预后因素(HR=1.02;95%CI=1.01-1.03;p<0.001)。
  • CT上钙化是OS的独立预后因素(HR=0.10;95%CI=0.02-0.50;p=0.005)。

临床应用与阅片要点

  • 在术前MRI报告中应准确测量肿瘤长轴直径,因其与长期生存独立相关。
  • 若患者有术前CT,应关注并报告钙化是否存在,钙化提示预后较好。
  • 结合组织学分级、MRI大小和CT钙化可综合评估四肢滑膜肉瘤患者的预后。

局限性

  • 回顾性研究设计。
  • 仅部分患者(34/98,35%)有CT扫描,钙化分析基于该亚组。
  • 样本量有限(98例),可能影响统计效能和泛化性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Synovial sarcomas (SS) of the extremities are rare soft tissue sarcomas that are more common in young adults. We deciphered the imaging phenotype of SS with the aim to determine if imaging could provide an incremental value to currently known prognostic factors (PF)-age and histological grade-to predict long-term overall survival (OS).

METHODS: This retrospective multicenter study included consecutive pediatric and adult patients with synovial sarcomas of the extremities from December 2002 to August 2020. Inclusion criteria were (i) a follow-up greater than 5 years and (ii) available pre-therapeutic MRI. A subset analysis included MRI and CT-scan. Clinical, pathological, and imaging variables were collected in all patients. The primary endpoint was to evaluate the association of these variables with OS using univariate and multivariate Cox regressions.

RESULTS: Out of 428 patients screened for eligibility, 98 patients (mean age: 37.1 ± 15.2 years) were included (MRI: n = 98/98, CT scan: n = 34/98; 35%). The median OS was 75.25 months (IQR = 55.50-109.12) and thirty-six patients (n = 36/98;37%) died during follow-up. The recurrence rate was 12.2% (n =12/98). SS lesions were mostly grade 2 (57/98; 58%). On MRI, SS had a mean long-axis diameter of 67.5 ± 38.3 mm. On CT scan, 44% (15/34) were calcified. Grade (hazard ratio [HR] = 2.71; 95%CI = 1.30-5.66; p = 0.008), size of the lesions evaluated on MRI (HR = 1.02; 95% CI = 1.01-1.03; p < 0.001), and calcifications on CT scan (HR = 0.10; 95% CI = 0.02-0.50; p = 0.005) were independent PF of OS.

CONCLUSIONS: This study demonstrated that imaging biomarkers can be used to predict long-term outcome in patients with SS. Strikingly, the presence of calcifications on CT scan is associated with favorable outcome and provides an incremental value over existing PF such as age, grade, and size.

KEY POINTS: • Beyond its diagnostic value, MRI is a pre-operative prognostic tool in synovial sarcomas of the extremities since the size of the lesion is an important prognostic factor. • Calcifications on CT scans are independently and significantly associated with prolonged overall survival.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Tordjman, Honoré, Crombé, et al. Prognostic factors of the synovial sarcoma of the extremities: imaging does matter. Eur Radiol. 2022. PMID: 35980435. doi:10.1007/s00330-022-09049-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。